ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05133	Pertussis	3/4	87/7206	6.74185597943e-06
ko04932	Non-alcoholic fatty liver disease (NAFLD)	3/4	182/7206	6.22314212663e-05
ko05134	Legionellosis	2/4	74/7206	0.000615989037098
ko04668	TNF signaling pathway	2/4	120/7206	0.001614434015
ko05142	Chagas disease (American trypanosomiasis)	2/4	130/7206	0.00189240130352
ko05160	Hepatitis C	2/4	153/7206	0.00261303528571
ko05164	Influenza A	2/4	167/7206	0.00310666828091
ko05161	Hepatitis B	2/4	173/7206	0.00333085657869
ko04210	Apoptosis	2/4	180/7206	0.00360193760092
ko04060	Cytokine-cytokine receptor interaction	2/4	191/7206	0.00404855542538
ko05167	Kaposi's sarcoma-associated herpesvirus infection	2/4	191/7206	0.00404855542538
ko05010	Alzheimer's disease	2/4	202/7206	0.00452024747811
ko05332	Graft-versus-host disease	1/4	18/7206	0.00995636331817
ko05330	Allograft rejection	1/4	24/7206	0.0132585698593
ko05320	Autoimmune thyroid disease	1/4	29/7206	0.0160040925539
ko05143	African trypanosomiasis	1/4	32/7206	0.01764865364
ko04940	Type I diabetes mellitus	1/4	32/7206	0.01764865364
ko05144	Malaria	1/4	45/7206	0.024751276258
ko05200	Pathways in cancer	2/4	492/7206	0.0254497024399
ko04215	Apoptosis - multiple species	1/4	47/7206	0.0258405592199
ko05219	Bladder cancer	1/4	48/7206	0.0263848583908
ko04622	RIG-I-like receptor signaling pathway	1/4	62/7206	0.0339811229605
ko04214	Apoptosis - fly	1/4	72/7206	0.0393797483854
ko04115	p53 signaling pathway	1/4	74/7206	0.0404567523021
ko01524	Platinum drug resistance	1/4	76/7206	0.0415328503488
ko05131	Shigellosis	1/4	82/7206	0.0447557143494
ko04657	IL-17 signaling pathway	1/4	87/7206	0.0474352198785
ko04917	Prolactin signaling pathway	1/4	87/7206	0.0474352198785
ko05323	Rheumatoid arthritis	1/4	89/7206	0.0485054421488